Some IBD Treatments in Pregnancy Had No Effect on Kids’ Infection Risk
Exposure to immunosuppressive monotherapies in utero did not increase serious infection risks in young children born to mothers with inflammatory bowel disease (IBD), but the same could not be said for exposures to combination therapies, a French population-based study found. Children up to 1 year of age who were exposed to tumor necrosis factor (TNF) […]
Safety Concerns Turn FDA Panel Thumbs Down for Novel CKD-Anemia Drug
An FDA advisory committee almost unanimously agreed that the risks were just too high for the chronic kidney disease (CKD)-related anemia drug roxadustat in any patient population. In a 13-1 vote Thursday, members of the Cardiovascular and Renal Drugs Advisory Committee felt that although there’s an unmet need for new anemia therapeutics, this particular drug […]